HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
100.20
-0.07 (-0.07%)
Nov 12, 2024, 4:00 PM EST - Market closed
HealthEquity Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 - 2015 |
| Revenue | 1,099 | 999.59 | 861.75 | 756.56 | 733.57 | 531.99 | Upgrade
|
| Revenue Growth (YoY) | 17.19% | 16.00% | 13.90% | 3.13% | 37.89% | 85.21% | Upgrade
|
| Cost of Revenue | 385.44 | 376.95 | 369.81 | 331.79 | 318.24 | 206.08 | Upgrade
|
| Gross Profit | 713.69 | 622.64 | 491.94 | 424.77 | 415.33 | 325.91 | Upgrade
|
| Selling, General & Admin | 206.02 | 182.93 | 166.32 | 144.04 | 134.46 | 104.51 | Upgrade
|
| Research & Development | 225.52 | 218.81 | 193.38 | 157.36 | 124.81 | 77.58 | Upgrade
|
| Operating Expenses | 534.5 | 494.5 | 454.28 | 384.2 | 335.33 | 216.79 | Upgrade
|
| Operating Income | 179.19 | 128.13 | 37.65 | 40.57 | 80 | 109.12 | Upgrade
|
| Interest Expense | -54.41 | -55.46 | -48.42 | -36.57 | -34.88 | -24.77 | Upgrade
|
| Interest & Investment Income | 15.04 | 12.14 | 1.76 | 1.5 | 1.05 | 5.91 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.31 | 0.66 | -0.44 | 1.71 | 5.08 | -1.93 | Upgrade
|
| EBT Excluding Unusual Items | 139.51 | 85.48 | -9.45 | 7.2 | 51.25 | 88.32 | Upgrade
|
| Merger & Restructuring Charges | -8.85 | -10.44 | -28.65 | -75.64 | -47.11 | -72.92 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 1.69 | - | 27.76 | Upgrade
|
| Pretax Income | 130.66 | 75.04 | -38.1 | -66.74 | 4.14 | 43.16 | Upgrade
|
| Income Tax Expense | 24.99 | 19.33 | -11.95 | -22.45 | -4.69 | 3.49 | Upgrade
|
| Net Income | 105.67 | 55.71 | -26.14 | -44.29 | 8.83 | 39.66 | Upgrade
|
| Net Income to Common | 105.67 | 55.71 | -26.14 | -44.29 | 8.83 | 39.66 | Upgrade
|
| Net Income Growth | 723.95% | - | - | - | -77.73% | -46.33% | Upgrade
|
| Shares Outstanding (Basic) | 86 | 86 | 84 | 83 | 74 | 67 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 87 | 84 | 83 | 76 | 68 | Upgrade
|
| Shares Change (YoY) | 3.02% | 2.98% | 1.57% | 9.85% | 10.56% | 8.02% | Upgrade
|
| EPS (Basic) | 1.22 | 0.65 | -0.31 | -0.53 | 0.12 | 0.59 | Upgrade
|
| EPS (Diluted) | 1.20 | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 | Upgrade
|
| EPS Growth | 694.69% | - | - | - | -79.48% | -50.43% | Upgrade
|
| Free Cash Flow | 305.17 | 241.13 | 147.28 | 132.09 | 168.53 | 97.72 | Upgrade
|
| Free Cash Flow Per Share | 3.46 | 2.77 | 1.74 | 1.59 | 2.23 | 1.43 | Upgrade
|
| Gross Margin | 64.93% | 62.29% | 57.09% | 56.14% | 56.62% | 61.26% | Upgrade
|
| Operating Margin | 16.30% | 12.82% | 4.37% | 5.36% | 10.91% | 20.51% | Upgrade
|
| Profit Margin | 9.61% | 5.57% | -3.03% | -5.85% | 1.20% | 7.46% | Upgrade
|
| Free Cash Flow Margin | 27.76% | 24.12% | 17.09% | 17.46% | 22.97% | 18.37% | Upgrade
|
| EBITDA | 337.43 | 281.21 | 198.85 | 177.76 | 195.91 | 164.47 | Upgrade
|
| EBITDA Margin | 30.70% | 28.13% | 23.08% | 23.50% | 26.71% | 30.92% | Upgrade
|
| D&A For EBITDA | 158.24 | 153.08 | 161.2 | 137.19 | 115.9 | 55.35 | Upgrade
|
| EBIT | 179.19 | 128.13 | 37.65 | 40.57 | 80 | 109.12 | Upgrade
|
| EBIT Margin | 16.30% | 12.82% | 4.37% | 5.36% | 10.91% | 20.51% | Upgrade
|
| Effective Tax Rate | 19.12% | 25.76% | - | - | - | 8.09% | Upgrade
|
| Revenue as Reported | 1,099 | 999.59 | 861.75 | 756.56 | 733.57 | 531.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.